Hanna R Rosenheck (Hanna Rosenheck)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

High Throughput

Top Venues

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Vishnu Kumarasamy, Jianxin Wang, Costakis Frangou, Yin Wan, Andrew Dynka, Hanna R Rosenheck, Prasenjit Dey, Ethan V Abel, Erik S Knudsen, Agnieszka K Witkiewicz
The extracellular niche and tumor microenvironment enhance KRAS inhibitor efficacy in pancreatic cancer. Cancer research (2024)
Vishnu Kumarasamy, Jianxin Wang, Costakis Frangou, Yin Wan, Andrew Dynka, Hanna R Rosenheck, Prasenjit Dey, Ethan V Abel, Erik S Knudsen, Agnieszka K Witkiewicz
The extracellular niche and tumor microenvironment enhance KRAS inhibitor efficacy in pancreatic cancer. Cancer research (2024)
Vishnu Kumarasamy, Jianxin Wang, Costakis Frangou, Yin Wan, Andrew Dynka, Hanna R Rosenheck, Prasenjit Dey, Ethan V Abel, Erik S Knudsen, Agnieszka K Witkiewicz
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer. Cancer research 84 (7) (2024)
Vishnu Kumarasamy, Jianxin Wang, Costakis Frangou, Yin Wan, Andrew Dynka, Hanna R Rosenheck, Prasenjit Dey, Ethan V Abel, Erik S Knudsen, Agnieszka K Witkiewicz
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer. Cancer research 84 (7) (2024)
Christos Fountzilas, David L Bajor, Sarbajit Mukherjee, Joel Saltzman, Agnieszka K Witkiewicz, Orla Maguire, Hans Minderman, Ram Nambiar, Hanna R Rosenheck, Erik S Knudsen, Jason B Muhitch, Scott I Abrams, Chong Wang, Alan D Hutson, Kristopher Attwood, Karen A Hicks, Jennifer A Jurcevic, Pawel Kalinski, Renuka Iyer, Patrick M Boland
Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)